925
Views
39
CrossRef citations to date
0
Altmetric
Reviews

The effects of curcumin supplementation on body weight, body mass index and waist circumference: a systematic review and dose-response meta-analysis of randomized controlled trials

, , , &
Pages 171-180 | Received 24 May 2018, Accepted 27 Aug 2018, Published online: 29 Oct 2018

References

  • Aggarwal, B. B., Y.-J. Surh, and S. Shishodia. 2007. The molecular targets and therapeutic uses of curcumin in health and disease. Springer, US: Springer Science & Business Media.
  • Ammon, H. P., and M. A. Wahl. 1991. Pharmacology of curcuma longa. Planta Medica 57(1):1–7.
  • Anand, P., A. B. Kunnumakkara, R. A. Newman, and B. B. Aggarwal. 2007. Bioavailability of curcumin: problems and promises. Molecular Pharmaceutics 4(6):807–18.
  • Bradford, P. G. 2013. Curcumin and obesity. Biofactors (Oxford, England) 39(1):78–87.
  • Campbell, M. S., A. J. Berrones, I. M. Krishnakumar, R. J. Charnigo, P. M. Westgate, and B. S. Fleenor. 2017. Responsiveness to curcumin intervention is associated with reduced aortic stiffness in young, obese men with higher initial stiffness. Journal of Functional Foods 29:154–60.
  • Chainani-Wu, N. 2003. Safety and anti-inflammatory activity of curcumin: A component of tumeric (curcuma longa). The Journal of Alternative & Complementary Medicine 9(1):161–8.
  • Chattopadhyay, I., K. Biswas, U. Bandyopadhyay, and R. K. Banerjee. 2004. Turmeric and curcumin: Biological actions and medicinal applications. Current Science-Bangalore 87:44–53.
  • Chuengsamarn, S., S. Rattanamongkolgul, R. Luechapudiporn, C. Phisalaphong, and S. Jirawatnotai. 2012. Curcumin extract for prevention of type 2 diabetes. Diabetes Care 35(11):2121–7.
  • DI Pierro, F., A. Bressan, D. Ranaldi, G. Rapacioli, L. Giacomelli, and A. Bertuccioli. 2015. Potential role of bioavailable curcumin in weight loss and omental adipose tissue decrease: preliminary data of a randomized, controlled trial in overweight people with metabolic syndrome. Preliminary study. European Review for Medical and Pharmacological Sciences 19:4195–202.
  • Donkin, I., S. Versteyhe, L. R. Ingerslev, K. Qian, M. Mechta, L. Nordkap, B. Mortensen, E. V. R. Appel, N. Jørgensen, V. B. Kristiansen., et al. 2016. Obesity and bariatric surgery drive epigenetic variation of spermatozoa in humans. Cell Metabolism 23(2):369–78.
  • Dulloo, A. G. 2011. The search for compounds that stimulate thermogenesis in obesity management: from pharmaceuticals to functional food ingredients. Obesity Reviews: An Official Journal of the International Association for the Study of Obesity 12(10):866–83.
  • Gearon, E., S. K. Tanamas, C. Stevenson, V. H. Loh, and A. Peeters. 2017. Changes in waist circumference independent of weight: Implications for population level monitoring of obesity. Preventive Medicine 111:378–83.
  • Golbidi, S., A. Mesdaghinia, and I. Laher. 2012. Exercise in the metabolic syndrome. Oxidative Medicine and Cellular Longevity 2012:349710.
  • Hamilton, L. C. 2012. Statistics with stata: version 12. Boston, US: Cengage Learning.
  • Hariri, M., and F. Haghighatdoost. 2018. Effect of curcumin on anthropometric measures: A systematic review on randomized clinical trials. Journal of the American College of Nutrition 37(3): 1–8.
  • Heymsfield, S. B., and T. A. Wadden. 2017. Mechanisms, pathophysiology, and management of obesity. The New England Journal of Medicine 376(3):254–66.
  • Higgins, J. P., and S. Green. 2011. Cochrane handbook for systematic reviews of interventions. New jersey, US: John Wiley & Sons.
  • Hirosumi, J., G. Tuncman, L. Chang, C. Z. GöRGUN, K. T. Uysal, K. Maeda, M. Karin, and G. S. Hotamisligil. 2002. A Central role for JNK in obesity and insulin resistance. Nature 420(6913):333–6.
  • Hozo, S. P., B. Djulbegovic, and I. Hozo. 2005. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 5:13.
  • Hu, G.-X., H. Lin, Q.-Q. Lian, S.-H. Zhou, J. Guo, H.-Y. Zhou, Y. Chu, and R.-S. Ge. 2013. Curcumin as a potent and selective inhibitor of 11β-hydroxysteroid dehydrogenase 1: Improving lipid profiles in high-fat-diet-treated rats. PloS One 8(3):e49976.
  • Jadad, A. R., R. A. Moore, D. Carroll, C. Jenkinson, D. J. M. Reynolds, D. J. Gavaghan, and H. J. Mcquay. 1996. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Controlled Clinical Trials 17(1):1–12.
  • Jazayeri-Tehrani, S. A., S. M. Rezayat, S. Mansouri, M. Qorbani, S. M. Alavian, M. Daneshi-Maskooni, and M.-J. Hosseinzadeh-Attar. 2017. The nanocurcumin reduces appetite in obese patients with non-alcoholic fatty liver disease (nafld): A double-blind randomized placebo-controlled clinical trial. Nanomedicine Journal 7(7):e016914–76.
  • Khan, I. A., and E. A. Abourashed. 2011. Leung's encyclopedia of common natural ingredients: used in food, drugs and cosmetics. New jersey, US: John Wiley & Sons.
  • Knowler, W. C., S. E. Fowler, R. F. Hamman, C. A. Christophi, H. J. Hoffman, A. T. Brenneman, J. O. Brown-Friday, R. Goldberg, E. Venditti, and D. M. Nathan. 2009. 10-year Follow-up of diabetes incidence and weight loss in the diabetes prevention program outcomes study. Lancet 374(9702):1677–86.
  • Kumari, M., T. Chandola, E. Brunner, and M. Kivimaki. 2010. A nonlinear relationship of generalized and Central obesity with diurnal cortisol secretion in the whitehall II study. The Journal of Clinical Endocrinology & Metabolism 95(9):4415–23.
  • Kunnumakkara, A. B., D. Bordoloi, G. Padmavathi, J. Monisha, N. K. Roy, S. Prasad, and B. B. Aggarwal. 2017. Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases. British Journal of Pharmacology 174(11):1325–48.
  • Lee, Y. K., W. S. Lee, J. T. Hwang, D. Y. Kwon, Y. J. Surh, and O. J. Park. 2009. Curcumin exerts antidifferentiation effect through AMPKα-PPAR-γ in 3T3-L1 adipocytes and antiproliferatory effect through AMPKα-COX-2 in cancer cells. Journal of Agricultural and Food Chemistry 57(1):305–10.
  • Maheshwari, R. K., A. K. Singh, J. Gaddipati, and R. C. Srimal. 2006. Multiple biological activities of curcumin: a short review. Life Sciences 78(18):2081–7.
  • Mohammadi, A., H. R. Sadeghnia, M. Saberi-Karimian, H. Safarian, G. A. Ferns, M. Ghayour-Mobarhan, and A. Sahebkar. 2017. Effects of curcumin on serum vitamin E concentrations in individuals with metabolic syndrome. Phytotherapy Research 31(4):657–62.
  • Mohammadi, A., A. Sahebkar, M. Iranshahi, M. Amini, R. Khojasteh, M. Ghayour-Mobarhan, and G. A. Ferns. 2013. Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial. Phytotherapy Research 27(3):374–9.
  • Moher, D., D. Cook, A. Jadad, P. Tugwell, M. Moher, A. Jones, B. Pham, and T. Klassen. 1999. Assessing the quality of reports of randomised trials: implications for the conduct of meta-analyses. Health Technology Assessment 3(12):i–iv.
  • Moher, D., L. Shamseer, M. Clarke, D. Ghersi, A. Liberati, M. Petticrew, P. Shekelle, and L. A. Stewart. 2015. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic Reviews 4:1.
  • Mousavi, S. M., A. Sheikhi, H. K. Varkaneh, M. Zarezadeh, J. Rahmani, and A. Milajerdi. 2018. Effect of nigella sativa supplementation on obesity indices: A systematic review and Meta-analysis of randomized controlled trials. Complementary Therapies in Medicine 38:48–57.
  • Murdande, S. B., M. J. Pikal, R. M. Shanker, and R. H. Bogner. 2011. Aqueous solubility of crystalline and amorphous drugs: Challenges in measurement. Pharmaceutical Development and Technology 16(3):187–200.
  • Organization, W. H. 2017. Obesity and Overweight factsheet from the WHO. Health.
  • Panahi, Y., N. Khalili, E. Sahebi, S. Namazi, M. S. Karimian, M. Majeed, and A. Sahebkar. 2017. Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: A randomized controlled trial. Inflammopharmacology 25(1):25–31.
  • Panahi, Y., P. Kianpour, R. Mohtashami, R. Jafari, L. E. Simental-Mendia, and A. Sahebkar. 2016. Efficacy and safety of phytosomal curcumin in Non-Alcoholic fatty liver disease: A randomized controlled trial. Drug Research 67(4):244–51. Available: http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/184/CN-01332184/frame.html.
  • Panahi, Y., P. Kianpour, R. Mohtashami, R. Jafari, L. E. Simental-MENDíA, and A. Sahebkar. 2017. Efficacy and safety of phytosomal curcumin in non-alcoholic fatty liver disease: a randomized controlled trial. Drug Research 67(04):244–51.
  • Pu, Y., H. Zhang, P. Wang, Y. Zhao, Q. Li, X. Wei, Y. Cui, J. Sun, Q. Shang, D. Liu, and Z. Zhu. 2013. Dietary curcumin ameliorates aging-related cerebrovascular dysfunction through the AMPK/uncoupling protein 2 pathway. Cellular Physiology and Biochemistry 32(5):1167–77.
  • Rahimi, H. R., A. H. Mohammadpour, M. Dastani, M. R. Jaafari, K. Abnous, M. Ghayour Mobarhan, and R. Kazemi Oskuee. 2016. The effect of nano-curcumin on HbA1c, fasting blood glucose, and lipid profile in diabetic subjects: A randomized clinical trial. Avicenna Journal of Phytomedicine 6:567–77.
  • Rahmani, S., S. Asgary, G. Askari, M. Keshvari, M. Hatamipour, A. Feizi, and A. Sahebkar. 2016. Treatment of non-alcoholic fatty liver disease with curcumin: A randomized placebo-controlled trial. Phytotherapy Research 30(9):1540–8.
  • Sahebkar, A. 2014. Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis. Phytotherapy Research : Ptr 28(5):633–42.
  • Scott, K. M., R. Bruffaerts, G. E. Simon, J. Alonso, M. Angermeyer, G. de Girolamo, K. Demyttenaere, I. Gasquet, J. M. Haro, E. Karam, et al. 2008. Obesity and mental disorders in the general population: results from the world mental health surveys. International Journal of Obesity 32(1):192–200.
  • Shao-Ling, W., L. Ying, W. Ying, C. Yan-Feng, N. Li-Xin, L. Song-Tao, and S. Chang-Hao. 2009. Curcumin, a potential inhibitor of up-regulation of TNF-alpha and IL-6 induced by palmitate in 3T3-L1 adipocytes through NF-kappaB and JNK pathway. Biomedical and Environmental Sciences 22(1):32–9.
  • Yang, Y. S., Y. F. Su, H. W. Yang, Y. H. Lee, J. I. Chou, and K. C. Ueng. 2014. Lipid-lowering effects of curcumin in patients with metabolic syndrome: a randomized, double-blind, placebo-controlled trial. Phytotherapy Research 28(12):1770–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.